189 related articles for article (PubMed ID: 8457648)
21. Evaluation of desmopressin effects on haemostasis in children with congenital bleeding disorders.
Hanebutt FL; Rolf N; Loesel A; Kuhlisch E; Siegert G; Knoefler R
Haemophilia; 2008 May; 14(3):524-30. PubMed ID: 18284449
[TBL] [Abstract][Full Text] [Related]
22. Desmopressin therapy to assist the functional identification and characterisation of von Willebrand disease: differential utility from combining two (VWF:CB and VWF:RCo) von Willebrand factor activity assays?
Favaloro EJ; Thom J; Patterson D; Just S; Dixon T; Koutts J; Baccala M; Rowell J; Baker R
Thromb Res; 2009 Apr; 123(6):862-8. PubMed ID: 19064279
[TBL] [Abstract][Full Text] [Related]
23. Laboratory assessment as a critical component of the appropriate diagnosis and sub-classification of von Willebrand's disease.
Favaloro EJ
Blood Rev; 1999 Dec; 13(4):185-204. PubMed ID: 10741895
[TBL] [Abstract][Full Text] [Related]
24. Intranasal administration of demopressin (DDAVP) for type 1 and type 2A von Willebrand disease.
Mohri H; Hashimoto Y; Yamazaki E; Kanamori H; Okubo T
Hematopathol Mol Hematol; 1998; 11(2):109-15. PubMed ID: 9608359
[TBL] [Abstract][Full Text] [Related]
25. 1-Desamino-8-arginine-vasopressin corrects the hemostatic defects in type 2B von Willebrand's disease.
McKeown LP; Connaghan G; Wilson O; Hansmann K; Merryman P; Gralnick HR
Am J Hematol; 1996 Feb; 51(2):158-63. PubMed ID: 8579058
[TBL] [Abstract][Full Text] [Related]
26. Laboratory testing for von Willebrand's disease: an assessment of current diagnostic practice and efficacy by means of a multi-laboratory survey. RCPA Quality Assurance Program (QAP) in Haematology Haemostasis Scientific Advisory Panel.
Favaloro EJ; Smith J; Petinos P; Hertzberg M; Koutts J
Thromb Haemost; 1999 Oct; 82(4):1276-82. PubMed ID: 10544913
[TBL] [Abstract][Full Text] [Related]
27. Mild forms of von Willebrand disease: diagnosis and management.
Federici AB
Curr Hematol Rep; 2003 Sep; 2(5):373-80. PubMed ID: 12932308
[TBL] [Abstract][Full Text] [Related]
28. Inconsistency of association between type 1 von Willebrand disease phenotype and genotype in families identified in an epidemiological investigation.
Castaman G; Eikenboom JC; Bertina RM; Rodeghiero F
Thromb Haemost; 1999 Sep; 82(3):1065-70. PubMed ID: 10494765
[TBL] [Abstract][Full Text] [Related]
29. Response to desmopressin in type IID von Willebrand's disease.
Thomas N; O'Callaghan U; Lowe GD; Olszynski V; Kernoff PB; Abildgaard CF; Tuddenham EG
Clin Lab Haematol; 1989; 11(3):189-97. PubMed ID: 2591151
[TBL] [Abstract][Full Text] [Related]
30. A variant of von Willebrand's disease characterized by recessive inheritance and missing triplet structure of von Willebrand factor multimers.
Mannucci PM; Lombardi R; Pareti FI; Solinas S; Mazzucconi MG; Mariani G
Blood; 1983 Nov; 62(5):1000-5. PubMed ID: 6605165
[TBL] [Abstract][Full Text] [Related]
31. A Reliable von Willebrand factor: ristocetin cofactor enzyme-linked immunosorbent assay to differentiate between type 1 and type 2 von Willebrand disease.
Vanhoorelbeke K; Cauwenberghs N; Vandecasteele G; Vauterin S; Deckmyn H
Semin Thromb Hemost; 2002 Apr; 28(2):161-6. PubMed ID: 11992239
[TBL] [Abstract][Full Text] [Related]
32. [Von Willebrand syndrome--risk of hemorrhage in ENT interventions in childhood].
Riechelmann H; Keller M; Ohler W
Laryngorhinootologie; 1994 Jun; 73(6):346-8. PubMed ID: 8060455
[TBL] [Abstract][Full Text] [Related]
33. Type 2B von Willebrand's disease due to Val1316Met mutation. Heterogeneity in the same sibship.
Rendal E; Penas N; Larrabeiti B; Pérez A; Vale A; López-Fernández MF; Batlle J
Ann Hematol; 2001 Jun; 80(6):354-60. PubMed ID: 11475150
[TBL] [Abstract][Full Text] [Related]
34. PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2.
van Vliet HH; Kappers-Klunne MC; Leebeek FW; Michiels JJ
Thromb Haemost; 2008 Sep; 100(3):462-8. PubMed ID: 18766263
[TBL] [Abstract][Full Text] [Related]
35. [Von Willebrand disease: characteristics and response to desmopressin. Study of 103 cases].
César JM; Avello AG; Vecino A; Cerveró C; Laraña JG; Fuertes IF; Villarrubia J; López J; de Oteyza JP; Velasco JL; Cantalapiedra A; Herrera P; Herrero S; Navarro JL
Med Clin (Barc); 1998 Nov; 111(16):601-3. PubMed ID: 9881332
[TBL] [Abstract][Full Text] [Related]
36. A first Taiwanese Chinese family of type 2B von Willebrand disease with R1306W mutation.
Shen MC; Lin JS; Lin DS; Hsu SC; Lin B
Thromb Res; 2003; 112(5-6):291-5. PubMed ID: 15041272
[TBL] [Abstract][Full Text] [Related]
37. von Willebrand disease R1374C: type 2A or 2M? A challenge to the revised classification. High frequency in the northwest of Spain (Galicia).
Penas N; Pérez-Rodríguez A; Torea JH; Lourés E; Noya MS; López-Fernández MF; Batlle J
Am J Hematol; 2005 Nov; 80(3):188-96. PubMed ID: 16247740
[TBL] [Abstract][Full Text] [Related]
38. Autosomal recessive von Willebrand disease associated with compound heterozygosity for a novel nonsense mutation (2908 del C) and the missense mutation C2362F: definite evidence for the non-penetrance of the C2362F mutation.
Castaman G; Bertoncello K; Bernardi M; Eikenboom JC; Budde U; Rodeghiero F
Am J Hematol; 2007 May; 82(5):376-80. PubMed ID: 17109387
[TBL] [Abstract][Full Text] [Related]
39. Multiple congenital coagulopathies co-expressed with Von Willebrand's disease: the experience of Hemophilia Region III Treatment Centers over 25 years and review of the literature.
Asatiani E; Kessler CM;
Haemophilia; 2007 Nov; 13(6):685-96. PubMed ID: 17973844
[TBL] [Abstract][Full Text] [Related]
40. [Prevalence, pathophysiology, diagnosis and treatment of von Willebrand syndrome in orthopedic trauma patients].
Kurth AA; Ludwig G; Scharrer I
Orthopade; 1999 Apr; 28(4):366-74. PubMed ID: 10335531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
